Transdermal and oral opioids for outpatient pain therapy. Comparing patients' characteristics by a claims data analysis;Transdermale und orale opioide in der ambulanten schmerztherapie. Vergleich von patientencharakteristika anhand einer GKV-datenanalyse

Schmerz

Volumn 22, Issue 2, 2008, Pages 156-163

  Hoer A ^a   Kurepkat, M ^a   Gottberg, A ^a   Haussler B ^a  

^a IGES Institut   (Germany)

Author keywords

Claims data analysis; Comparative study; Opioid patches; Transdermal opioids

Indexed keywords

ANTIDEPRESSANT AGENT; BUPRENORPHINE; FENTANYL; HYDROMORPHONE; LAXATIVE; MORPHINE; OPIATE; OXYCODONE;

ARTICLE; CONTROLLED STUDY; HUMAN; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTPATIENT CARE; PAIN; PRESCRIPTION; STATISTICAL ANALYSIS; UNIVARIATE ANALYSIS;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ADULT; AGED; AMBULATORY CARE; ANALGESICS, OPIOID; DELAYED-ACTION PREPARATIONS; DRUG THERAPY, COMBINATION; FAMILY PRACTICE; FEMALE; GERMANY; HUMANS; INSURANCE CLAIM REVIEW; MALE; MIDDLE AGED; PAIN MEASUREMENT; PRESCRIPTIONS, DRUG; REGRESSION ANALYSIS;

EID: 43449125953     PISSN: 0932433X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00482-007-0575-y     Document Type: Article

References (8)

1. Schwabe U, Paffrath D (Hrsg) (2006) Arzneiverordnungs-Report 2006. Springer, Berlin Heidelberg New York
2. WHO (1990) Cancer pain relief and palliative care. Report of a WHO expert committee. Technical report series, No. 804., WHO, Geneva
3. Fricke U, Günther J, Zawinell A (2006b) Anatomisch-therapeutisch- chemische Klassifikation mit Tagesdosen für den deutschen Arzneimittelmarkt. Methodik der ATC-Klassifikation und DDD-Festlegung. Hrsg. vom Wissenschaftlichen Institut der AOK (WIdO), Bonn
4. DGS (2005) Versinkt Deutschland am 1. April im Schmerz? Pressemitteilung vom 17.2.2005; http://www.schmerz-therapie-deutschland.de/pages/presse/2005/ Versinkt_Deutschland_am_1_April_im_Schmerz.htm [28.4.2006]
5. Allan L, Hays H, Jensen NH et al. (2001) Randomized crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain. BMJ 322: 1154-1158
6. Schwarzer A, Nauck F, Klaschik E (2005) Strong opioids and constipation. Schmerz 19: 214-219
7. Radbruch L, Sabatowski R, Loick G et al. (2000) Constipation and the use of laxatives: a comparison between transdermal fentanyl and oral morphine. Palliat Med 14: 111-119
8. Radbruch L (2003) Buprenorphine TDS: use in daily practice, benefits for patients. Int J Clin Pract 133 [suppl]: 19-22; discussion 23-24